Copyright
©The Author(s) 2025.
World J Diabetes. Apr 15, 2025; 16(4): 101310
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.101310
Published online Apr 15, 2025. doi: 10.4239/wjd.v16.i4.101310
Table 1 Characteristics of included studies
Year | Ref. | Country | Design | Type of model (D/V) | Collecting time | Sample size (D/V) | Outcome measure | Age (SD) (years) |
2019 | Ning et al[11] | China | Case-control study | D | January 2017-June 2018 | 452/- | DPN occurs | 53.62 ± 12.79 |
2020 | Metsker et al[22] | Russia | Cross-sectional study | D, V | July 2010-August 2017 | 4340/1085 | DPN occurs | - |
2021 | Wu et al[17] | China | Prospective cohort study | D, V | September 2018-July 2019 | 460/152 | DPN occurs | 65 |
2021 | Fan et al[21] | China | Real-world study | D, V | January 2010-December 2015 | 132/33 | DPN occurs | - |
2022 | Zhang et al[18] | China | Case-control study | D, V | February 2017-May 2021 | 519/259 | DPN occurs | D: 57.76 ± 12.95; V: 58.97 ± 12.49 |
2022 | Li et al[10] | China | Retrospective cohort study | D, V | 2010-2019 | 11265/3755 | DPN occurs | 60.3 ± 10.9 |
2023 | Tian et al[20] | China | Cross-sectional study | D, V | January 2019-October 2020 | 3297/1426 | DPN occurs | - |
2023 | Li et al[15] | China | Retrospective cohort study | D, V | D: January 2017-December 2020; V: January 2019-December 2020 | 3012/901 | DPN occurs | D: 57.12 ± 12.23; V: 56.60 ± 12.03 |
2023 | Lian et al[16] | China | Retrospective cohort study | D, V | February 2020-July 2022 | 895/383 | DPN occurs | 64.5 (55.0–72.0) |
2023 | Liu et al[19] | China | Retrospective cohort study | D, V | September 2010-September 2020 | 95604/462 | DPN occurs | 52.4 ± 12.2 |
2023 | Wang et al[12] | China | Case-control study | D | March 2021-March 2023 | 500/- | DPN occurs | 56.8 ± 10.22 |
2023 | Zhang et al[13] | China | Case-control study | D | April 2019-May 2020 | 323/- | DPN occurs | 55.36 ± 11.25 |
2023 | Gelaw et al[14] | Ethiopia | Prospective cohort study | D | January 2005-December 2021 | 808/- | DPN occurs | 45.6 ± 3.1 |
2022 | Baskozos et al[23] | Multi center | Cross-sectional study | D, V | 2012-2019 | 935/295 | Painful or painless DPN occurs | D: 68 (60-74); V: 69 (63-77) |
Table 2 Characteristics of studies included in the development and validation of the model
Ref. | Modeling method | Variable selection methods | Methods for handling continuous variables | Missing data | Predictors in the final model | Model performance | Model presentation | Internal validation | External validation | ||
Quantity | Processing method | Discrimination | Calibration | ||||||||
Ning et al[11] | Logistic regression | Monofactor analysis | Maintaining continuity | - | - | Duration of DM/FPG/FINS/HbA1c/HOMA-IR/Vaspin/Omentin-1 | AUC = 0.789 (0.741-0.873) | Calibration curve | Nomogram | Bootstrap | None |
Metsker et al[22] | Artificial neural network/support vector machine/decision tree/linear regression/logistic regression | - | - | - | Delete, replace | Unsatisfactory control of glycemia/systemic inflammation/renal dyslipidemia/dyslipidemia/macroangiopathy | (1) AUC = 0.8922; (2) AUC = 0.8644; (3) AUC = 0.8988; (4) AUC = 0.8926; and (5) AUC = 0.8941 | None | LIME explanation | 5-fold cross-validation | None |
Wu et al[17] | Logistic regression | LASSO regression | Maintaining continuity | 19 | - | FBG/PBG/LDL-C/age/TC/BMI/HbA1c | D: (1) AUC = 0.656; (2) AUC = 0.724; (3) AUC = 0.731; and (4) AUC = 0.713. V: (1) AUC = 0.629; (2) AUC = 0.712; (3) AUC = 0.813; and (4) AUC = 0.830 | Hosmer-Lemeshow test/Calibration Plot | Nomogram | None | Geographical |
Fan et al[21] | Machine learning | Monofactor analysis | Categorizing continuous variables | - | - | Age/duration of DM/duration of unadjusted hypoglycemic treatment (≥ 1 year)/number of insulin species/total cost of hypoglycemic drugs/number of hypoglycemic drugs/gender/genetic history of diabetes/dyslipidemia | (1) XF: AUC = 0.847 ± 0.081; (2) CHAID: AUC = 0.787 ± 0.081; (3) QUEST: AUC = 0.720 ± 0.06; and (4) D: AUC = 0.859 ± 0.05 | None | Variable Importance | Bootstrap | None |
Zhang et al[18] | Logistic regression | Monofactor analysis | Maintaining continuity | - | - | Age/gender/duration of DM/BMI/uric acid/HbA1c/FT3 | D: AUC = 0.763; V: AUC = 0.755 | Calibration curve | Nomogram | Bootstrap | None |
Li et al[10] | Logistic regression | LASSO regression | Maintaining continuity | - | - | Sex/age/DR/duration of DM/WBC/eosinophil fraction/lymphocyte count/HbA1c/GSP/TC/TG/HDL/LDL/ApoA1/ApoB | D: AUC = 0.858 (0.851-0.865); V: AUC = 0.852 (0.840-0.865) | Hosmer-Lemeshow Test/Calibration curve | Nomogram | Bootstrap | None |
Tian et al[20] | Logistic regression | LASSO regression | Categorizing continuous variables | - | - | Advanced age of grading/smoking/insomnia/sweating/loose teeth/dry skin/purple tongue | D: AUC = 0.727; V: AUC = 0.744 | Calibration curve | Nomogram | 5-fold cross-validation | None |
Li et al[15] | Logistic regression | LASSO regression | Maintaining continuity | - | - | Age/25(OH)D3/duration of T2DM/HDL/HbA1c/FBG | D: AUC = 0.8256 (0.8104-0.8408); V: AUC = 0.8608 (0.8376-0.8840) | Hosmer-lemeshow test/Calibration curve | Nomogram | Bootstrap | Geographical |
Lian et al[16] | Logistic regression machine learning | - | Maintaining continuity | 10 | Delete, multiple imputation, or leave unprocessed | Age/ALT/ALB/TBIL/UREA/TC/HbA1c/APTT/24-hUTP/urine protein concentration/duration of DM/neutrophil-to-lymphocyte Ratio/HOMA-IR | AUC = 0.818 | None | The Shapley additive explanations | 10-fold cross-validation | None |
Liu et al[19] | Β coefficient | - | Maintaining continuity | - | - | Age/smoking/BMI/duration of DM/HbA1c/low HDL-c/high TG/hypertension/DR/DKD/CVD | AUC = 0.831 (0.794-0.868) | None | - | None | Geographical |
Wang et al[12] | Logistic regression | Monofactor analysis | Maintaining continuity | - | - | Age/duration of DM/HbA1c/TG/2 hours CP/T3 | AUC = 0.938 (0.918-0.958) | Hosmer-lemeshow test/Calibration curve | Nomogram | Bootstrap | None |
Zhang et al[13] | Logistic regression | LASSO regression | Maintaining continuity | - | - | Age/smoking/dyslipidemia/HbA1c/glucose variability parameters | AUC = 0.647 (0.585-0.708) | Hosmer-lemeshow test/Calibration curve | Nomogram | Bootstrap | None |
Gelaw et al[14] | Logistic regression/machine learning | LASSO regression | Categorizing continuous variables | - | Multiple Imputation | Hypertension/FBG/other comorbidities/Alcohol consumption/Physical activity/type of DM treatment/WBC/RBC | (1) AUC = 0.732 (0.69-0.773); and (2) AUC = 0.702 (0.658-0.746) | Hosmer-lemeshow test | Nomogram | Bootstrap | None |
Baskozos et al[23] | Machine learning | - | - | - | Multiple imputation | Quality of life (EQ5D)/lifestyle (smoking, alcohol consumption)/demographics (age, gender)/personality and psychology traits (anxiety, depression, personality traits)/biochemical (HbA1c)/clinical variables (BMI, hospital stay and trauma at young age) | (1) AUC = 0.8184 (0.8167-0.8201); (2) AUC = 0.8188 (0.8171-0.8205); and (3) AUC = 0.8123 (0.8107-0.8140) | Calibration curve | The adaptive regression splines classifier | 10-fold cross-validation | Geographical |
Table 3 Comparison among different performances included in the model
Ref. | Discrimination | Sensibility | Specificity | Precision | F1 score | Recall rate | Accuracy | PPV | NPV |
Ning et al[11] | AUC = 0.789 (0.741-0.873) | ||||||||
Metsker et al[22] | (1) AUC = 0.8922; (2) AUC = 0.8644; (3) AUC = 0.8988; (4) AUC = 0.8926; and (5) AUC = 0.8941 | (1) ANN = 0.6736; (2) SVM = 0.6817; (3) Decision tree = 0.6526; (4) Linear Regression = 0.6777; and (5) Logistic Regression = 0.6826 | (1) ANN = 0.7342; (2) SVM = 0.7210; (3) Decision tree = 0.6865; (4) Linear Regression = 0.7299; and (5) Logistic Regression = 0.7232 | (1) ANN = 0.8090; (2) SVM = 0.7655; (3) Decision tree = 0.7302; (4) Linear Regression = 0.7911; and (5) Logistic Regression = 0.7693 | (1) ANN = 0.7471; (2) SVM = 0.7443; (3) Decision tree = 0.7039; (4) Linear Regression = 0.7472; and (5) Logistic Regression = 0.7384 | ||||
Wu et al[17] | D: (1) AUC = 0.656; (2) AUC = 0.724; (3) AUC = 0.731; and (4) AUC = 0.713; V; (1) AUC = 0.629; (2) AUC = 0.712; (3) AUC = 0.813; and (4) AUC = 0.830 | ||||||||
Fan et al[21] | (1) XF: AUC = 0.847 ± 0.081; (2) CHAID: AUC = 0.787 ± 0.081; (3) QUEST: AUC = 0.720 ± 0.06; and (4) D: AUC = 0.859 ± 0.05 | (1) XF: 0.783 ± 0.080; (2) CHAID: 0.757 ± 0.054; (3) QUEST: 0.766 ± 0.056; and (4) D: 0.843 ± 0.038 | (1) XF: 0.642 ± 0.123; (2) CHAID: 0.680 ± 0.143; (3) QUEST: 0.716 ± 0.186; and (4) D: 0.775 ± 0.092 | (1) XF: 0.882 ± 0.073; (2) CHAID: 0.807 ± 0.070; (3) QUEST: 0.805 ± 0.057; and (4) D: 0.885 ± 0.055 | |||||
Zhang et al[18] | D: AUC = 0.763; V: AUC = 0.755 | ||||||||
Li et al[10] | D: AUC = 0.858 (0.851-0.865); V: AUC = 0.852 (0.840-0.865) | 0.74 | 0.874 | ||||||
Tian et al[20] | D: AUC = 0.727; V: AUC = 0.744 | ||||||||
Li et al[15] | D: AUC = 0.8256 (0.8104-0.8408); V: AUC = 0.8608 (0.8376-0.8840) | ||||||||
Lian et al[16] | LR: 0.683 (0.586, 0.737); (2) KNN: 0.671 (0.607, 0.739); (3) DT: 0.679 (0.636, 0.759); (4) NB: 0.589 (0.543, 0.634); (5) RF: 0.736 (0.686,0.765); and (6) XGBoost: 0.764 (0.679, 0.801) | (1) LR: 0.687 ± 0.056; (2) KNN: 0.858 ± 0.070; (3) DT: 0.695 ± 0.032; (4) NB: 0.784 ± 0.087; (5) RF: 0.769 ± 0.026; and (6) XGBoost: 0.765 ± 0.040 | (1) LR: 0.672 ± 0.056; (2) KNN: 0.559 ± 0.070; (3) DT: 0.669 ± 0.042; (4) NB: 0.378 ± 0.071; (5) RF: 0.719 ± 0.027; and (6) XGBoost: 0.736 ± 0.050 | (1) LR: 0.659 ± 0.062; (2) KNN: 0.419 ± 0.073; (3) DT: 0.648 ± 0.067; (4) NB: 0.253 ± 0.061; (5) RF: 0.677 ± 0.040; and (6) XGBoost: 0.711 ± 0.066 | (1) LR: 0.679 ± 0.052; (2) KNN: 0.674 ± 0.039; (3) DT: 0.682 ± 0.032; (4) NB: 0.590 ± 0.029; (5) RF: 0.736 ± 0.021; and (6) XGBoost: 0.746 ± 0.041 | ||||
Liu et al[19] | AUC = 0.831 (0.794-0.868) | ||||||||
Wang et al[12] | AUC = 0.938 (0.918-0.958) | 0.846 | 0.668 | ||||||
Zhang et al[13] | AUC = 0.647 (0.585-0.708) | ||||||||
Gelaw et al[14] | (1) AUC = 0.732 (0.69-0.773); and (2) AUC = 0.702 (0.658-0.746) | (1): 0.652; and (2): 0.7209 | (1): 0.717; and (2): 0.577 | (1) 0.384; and (2) 0.315 | (1) 0.884; and (2) 0.884 | ||||
Baskozos et al[23] | (1) AUC = 0.8184 (0.8167-0.8201); (2) AUC = 0.8188 (0.8171-0.8205); and (3) AUC = 0.8123 (0.8107-0.8140) |
Table 4 Risk of bias and applicability assessment
Ref. | Risk of bias | Applicability | Overall | ||||||
Participants | Predictors | Outcome | Analysis | Participants | Predictors | Outcome | Risk of bias | Applicability | |
Ning et al[11] | + | - | + | - | - | + | + | - | - |
Metsker et al[22] | - | - | + | - | + | + | + | - | + |
Wu et al[17] | + | + | + | - | + | + | + | - | + |
Fan et al[21] | - | - | + | - | + | + | + | - | + |
Zhang et al[18] | + | - | - | - | + | + | + | - | + |
Li et al[10] | - | - | + | - | + | + | + | - | + |
Tian et al[20] | - | ? | - | - | + | - | - | - | - |
Li et al[15] | - | - | + | - | + | + | + | - | + |
Lian et al[16] | - | + | + | - | + | + | + | - | + |
Liu et al[19] | - | - | - | - | + | + | + | - | + |
Wang et al[12] | + | + | + | - | + | + | + | - | + |
Zhang et al[13] | + | - | + | - | - | + | + | - | - |
Gelaw et al[14] | + | + | + | - | + | + | + | - | + |
Baskozos et al[23] | - | - | + | - | + | + | + | - | + |
- Citation: Sun CF, Lin YH, Ling GX, Gao HJ, Feng XZ, Sun CQ. Systematic review and critical appraisal of predictive models for diabetic peripheral neuropathy: Existing challenges and proposed enhancements. World J Diabetes 2025; 16(4): 101310
- URL: https://www.wjgnet.com/1948-9358/full/v16/i4/101310.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i4.101310